BRCA1 and ovarian carcinoma: Unlike mutation carriers of BRCA1/2, ovarian cancer is not commonly seen in PABL2 mutation carriers; 26.6% of the BRCA1 developed personal ovarian cancer, while only 7.7% of PABL2 carriers developed ovarian cancer (p-value < 0.001).